Platelet count response to Helicobacter pylori eradication for idiopathic thrombocytopenic purpura in northeastern Brazil

• Autor(a) principal: Barbosa, Alzira Maria de Castro
• Data de Publicação: 2018
• Outros Autores: Ribeiro, Rosangela Albuquerque, Silva, Cícero Ígor Simões Moura, Cruz, Francisco Will Saraiva, Azevedo, Orleancio Gomes Ripardo de, Pitombeira, Maria Helena da Silva, Braga, Lucia Libanez Campelo
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da Universidade Federal do Ceará (UFC)
• Texto Completo: http://www.repositorio.ufc.br/handle/riufc/35287
• topic: Helicobacter pylori; Púrpura Trombocitopênica Idiopática; Purpura, Thrombocytopenic, Idiopathic

Background: Several studies have demonstrated that platelet counts in Helicobacter pyloripositive patients with chronic idiopathic thrombocytopenic purpura improved significantly after successful eradication of the infection. However, depending of the geographical region of the study the results have been highly divergent. Objective: The purpose of this studywas to evaluate the effect of H. pylori eradication therapy on platelet count in a cohort of chronic idiopathic thrombocytopenic purpura patients from northeastern Brazil. Method: H. pylori status was determined in 28 chronic idiopathic thrombocytopenic purpura patients using the rapid urease test and histology. H. pylori-positive patients received standard triple therapy for one week. The effect of the eradication therapy was evaluated using the 13C-urea breath test two to three months after treatment. Results: The prevalence of H. pylori infection was similar to that found in the general population. Twenty-two patients (78.5%) were H. pylori-positive. Fifteen were treated, 13 (86%) of whom successfully. At six months, 4/13 (30%) displayed increased platelet counts, which remained throughout follow-up (12 months). Platelet response was not associated to mean baseline platelet count, duration of chronic idiopathic thrombocytopenic purpura, gender, age, previous use of medication, or splenectomy.